Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 3, 2004, Pages 513-520

  Hata, F ^a   Nishimori, Hidefumi ^a   Yasoshima, T ^b   Tanaka, H ^a,b   Ohno, K ^a,b   Yanai, Y ^a,b   Ezoe, E ^a   Kamiguchi, K ^a   Isomura, H ^a   Denno, R ^a   Sato, N ^a   Hirata, H K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shinsapporo Keiaikai Hospital   (Japan)

Author keywords

Differential gene expression; DNA chip; Pancreatic cancer

Indexed keywords

ARTICLE; CELL LINE; CELL STRAIN; CELL STRAIN HPC 1; CELL STRAIN HPC 1H5; CELL STRAIN HPC 1P5A; CELL STRAIN HPC 3; CELL STRAIN HPC 3H4; CELL STRAIN HPC 3P4A; CELL STRAIN HPC 4; CELL STRAIN HPC 4H4; CELL STRAIN HPC 4P4A; CELL STRAIN PANC 1H5; CELL STRAIN PANC 1P5A; CELL STRAIN PANC1; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; SAMPLING;

CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; CLUSTER ANALYSIS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; SERINE ENDOPEPTIDASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 8544251285     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baker C.H., Solorzano C.C., Fidler I.J.: Angiogenesis and cancer metastasis: antiangiogenic therapy of human pancreatic adenocarcinoma. Int. J. Clin. Oncol. 6: 59-65, 2001.
2. Niizeki H., Kobayashi M. Horiuchi L., et al: Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br. J. Cancer. 86: 1914-1919, 2002.
3. Chambers A.F., Groom A.C., MacDonald I.C.: Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer. 2: 563-572, 2002.
4. Ramaswamy S., Golub T.R.: DNA microarray in clinical oncology. J. Clin. Oncol. 20: 1932-1941, 2002.
5. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R.: A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33: 49-54, 2003.
6. Nishimori, H., Yasoshima, Y., Denno, R., et al.: A New Peritoneal Dissemination Model Established from the Human Pancreatic Cancer Cell Line. Pancreas 22: 348-356, 2001.
7. Nishimori H., Yasoshima T., Hata F., et al.: A Novel Nude Mouse Model of Liver Metastasis and Peritoneal Dissemination from the Same Human Pancreatic Cancer Line. Pancreas 24: 242-250, 2002.
8. Nomura H., Nishimori H., Yasoshima T., et al.: A new liver metastatic and peritoneal dissemination model established from the same human pancreatic cancer cell line: analysis using cDNA macroarray. Clin. Exp. Met. 19: 391-399, 2002.
9. Buchholz M., Boeck W., Fensterer H., et al.: Use of DNA arrays/microarrays in pancreatic research. Pancreatology 1: 581-586, 2001.
10. Ji J., Chen X., Leung SY., et al.: Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 21: 6549-6556, 2002.
11. Mori M., Mimori K., Yoshikawa Y., et al.: Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 131: S39-47, 2002.
12. Alon U., Barkai N., Notterman D.A., et al.: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. 96: 6745-6750, 1999.
13. Notterman D.A., Alon U., Sierk A.J. Levine J.: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma and normal tissue examined by oligonucleotide arrays. Cancer Res. 61: 3124-3130, 2001.
14. Sallinen S.L., Sallinen P.K., Haapasalo H.K., et al.: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60: 6617-6622, 2000.
15. Nemoto T., Ohashi K., Akashi T., Johnson J.D., Hirokawa K.: Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology 65: 195-203, 1997.
16. Barker K.T., Martindale J.E., Mitchell P.J., et al.: Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast cancer. Oncogene 10: 569-575, 1995.
17. Samant R.S., Debies M.T., Shevde L.A., Verderame M.F., Welch D.R.: Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Int. J. Cancer 97: 15-20, 2002.
18. Mousses S., Bubendolf L., Wagner U., et al.: Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res. 62: 1256-1260, 2002.
19. Jurcevic T.C., Efthimiou E., Mielsen T., et al.: Expression profiling of microdissesected pancreatic adenocarcinomas. Oncogene 21: 4587-4594, 2002.
20. Waldegger S., Barth P., Raber G., Lang F.: Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonix and isotonic alterations of cell volume. Proc. Natl. Acad. Sci. 94: 4440-4445, 1997.
21. Uemura H., Chang C.: Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment. Endocrinology 139: 2329-2334, 1998.
22. Fisher J.L., Field C.L., Zhou H., Harris T.L., Henderson M.A., Chong P.P.: Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases - a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Breast Cancer Res. Treat. 61: 1-12, 2000.
23. Abe J., Urano T., Konno H., et al.: Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size. Cancer 86:2602-2611, 1999.
24. Engel I., Murre C.: Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc. Natl. Acad. Sci. 99: 11322-11327, 2002.
25. Smith L.E., Shen W., Perruzzi C., et al.: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 5: 1390-1395, 1999.
26. Hakam A., Yeatman T.J., Lu L., et al.: Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum. Pathol. 30: 1128-1133, 1999.